After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, NVAX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Novavax, Inc. is $1.66B. A total of 4.72 million shares were traded on the day, compared to an average of 17.54M shares.
In the most recent transaction, YOUNG JAMES F sold 7,500 shares of NVAX for 14.09 per share on Jun 21 ’24. After the transaction, the Director now owns 61,760 company shares. In a previous transaction on Jun 18 ’24, YOUNG JAMES F sold 7,500 shares at 13.72 per share. NVAX shares that Director owns now total 69,260.
Among the insiders who sold shares, Dubovsky Filip disposed of 13,904 shares on Jun 17 ’24 at a per-share price of $14.47. This resulted in the President, R&D holding 66,613 shares of NVAX after the transaction. In another insider transaction, Dubovsky Filip sold 47,312 shares at $13.90 per share on May 14 ’24. Company shares held by the President, R&D now total 38,953.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, NVAX has a high of $23.86 and a low of $3.53.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. NVAX’s latest balance sheet shows that the firm has $1.52B in Cash & Short Term Investments as of fiscal 2021. There were $453.99M in debt and $2.39B in liabilities at the time. Its Book Value Per Share was -$2.70, while its Total Shareholder’s Equity was -$351.67M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVAX is Buy with a score of 3.67.
